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Summary Mean values of extracellular pH (pH,) in tumours tend to be about 0.5 pH units lower than in
normal tissues, whereas values of intracellular pH (pHi) in tumours and normal tissues are similar. Previous
studies have shown that drugs that acidify cells at lower pHe such as nigericin, used alone or with agents that
inhibit the regulation of pH,, have toxicity to cultured cells at pH,<6.5 in short-term exposure; these agents
also lead to modest anti-tumour effects in mice when given acutely. To evaluate the long-term effects of these
drugs at levels ofpHe that might occur commonly in tumours, we exposed cells for up to 72 h at pHe 6.8 or 7.2
in vitro. Nigericin (0.033 gM) caused time-dependent cell killing of murine KHT and EMT-6 cells at pHe 6.8
(but not at pHe 7.2) with a surviving fraction approximately 5 x 10-3 after 72 h exposure. Cell killing was
increased in the presence of 4,4-diisothiocyanstilbene 2,2-disulphonic acid (DIDS), an inhibitor of Na+-
dependent HCO3-/Cl- exchange, and to a lesser extent in the presence of 5-(N-ethyl-N-isopropyl) amiloride
(EIPA), an inhibitor of Na+/H+ exchange. Cell killing was exquisitely sensitive to the level of pHe. Osmotic
pumps were used to obtain a 72 h continuous infusion of nigericin in mice; this led to dose-dependent killing of
cells in KHT tumours with surviving fraction of approximately 0.1 at maximum tolerated doses. Hydralazine,
which may cause tumour hypoxia and lower pHi as well as pH,, caused cytotoxity when given alone by chronic
infusion, and enhanced the cytotoxicity due to nigericin. The addition of DIDS and/or EIPA (using two
pumps) further enhanced anti-tumour toxicity, with a surviving fraction of approximately 0.002 at tolerated
doses of the four drugs used to treat KHT tumours. The experiments demonstrate the activity of drugs that
inhibit the regulation of pHi against murine tumours when delivered by chronic infusion.
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Limited vascularisation of solid tumours often leads to
inadequate delivery of oxygen and other nutrients to some
tumour cells and to poor clearance of metabolic products as
compared with normal tissues (Tannock, 1968). Tumour cells
tend to metabolise glucose by glycolysis even under well-
oxygenated conditions. Especially in hypoxic regions, tumour
cells depend on anaerobic glycolysis as an energy source with
consequent production of lactic acid, and clearance of this
and other acids produced by metabolism may lead to tumour
acidity. Measurements of extracellular pH (pHe) using
microelectrodes have shown that the pHe of tumours is on
average about 0.5 pH units lower than that of normal tissues,
with tumour pHe typically in the range 6.6-7.0 and normal
tissue pHe between pH, 7.1 and 7.6 (Wike-Hooley et al.,
1984). Although pH, in solid tumours tends to be acidic,
intracellular pH (pH,) measured by 3"P-nuclear magnetic
resonance (NMR) spectroscopy is usually found to have
similar values in solid tumours and normal tissues (Vaupel et
al., 1989). Gillies et al. (1994) have measured pH, and pHe in
tumours simultaneously using an extracellular pH marker
and confirmed that tumour pHe was about 0.5 pH units
lower than pHi in the same tumour. These results indicate
that tumour cells are exposed frequently to an acidic
environment and that the cells have active mechanisms that
regulate their pH, to physiological levels.
The difference in pH, between tumours and normal tissues
provides an opportunity for tumour-selective therapy through
the development of drugs that have increased toxicity at low
PHe (Tannock and Rotin, 1989). Agents with this property
include ionophores, such as nigericin, which abolish the pH
gradient across the cell membrane. The viability of cells in an
acidic microenvironment also depends on the activity of
membrane-based exchangers that regulate pHi (Rotin et al.,
1989). Two major exchangers known to be involved in the
regulation of pH, under acidic conditions are the Na+/H+
antiport (Johnson and Epel, 1976; Aronson et al., 1982;
Moolenaar et al., 1984) and the Na+-dependent HCO3 /Cl1
exchanger (Thomas, 1977; L'Allemain et al., 1985; Cassel et
al., 1988). The former is inhibited by amiloride and its
substituted analogues, and the latter is inhibited by stilbene
derivatives such as DIDS (4,4-diisothiocyanstilbene 2,2-
disulphonic acid).
Our previous studies have shown that the ionophore
nigericin leads to intracellular acidification and is toxic to
tumour cells under acidic conditions in vitro (Rotin et al.,
1987). Nigericin also causes cellular acidification in a murine
tumour, and when combined with hydralazine, which
decreases tumour blood flow, leads to killing of tumour
cells (Newell et al., 1992). In a previous study comparing
three analogues of amiloride, 5-(N-ethyl-N-isopropyl) amilor-
ide (EIPA) was found to be 200-fold more potent than
amiloride in inhibiting Na+/H+ antiport activity (Maidorn et
al., 1993). Increased killing of tumour cells was found after
injection of nigericin, EIPA and hydralazine into mice, but
the surviving fraction was generally >10' (Hasuda et al.,
1994). Others have shown that the combination of nigericin
and DIDS augments the effect of hyperthermia on tumour
growth when both drugs are given before heating an
experimental tumour (Lyons et al., 1993).
Previous experiments have studied the effects of agents
such as nigericin, EIPA or DIDS, given as short-term
exposures of up to 6 h in vitro or by bolus injection in vivo.
Major toxicity in cell culture has been observed at pH. <6.5
but, as tumour pH, is generally higher than 6.5, it is not
surprising that only limited cell kill has been observed in vivo.
Long-term exposure to amiloride has been shown to cause
the inhibition of proliferation of cells in culture (Szolgay-
Daniel et al., 1991). Sparks et al. (1983) have demonstrated
suppression of growth of the H6 hepatoma and DMA/J
mammary carcinoma in mice treated repeatedly with
amiloride. Agents that inhibit the regulation of pH, are
dose- and time-dependent in their cytotoxic effects, so that
long-term exposure might lead to increased cell killing at
levels of pH, found commonly in solid tumours. The aim of
the present study was to determine if prolonged exposure to
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Materials and methods
Cell lines
Exponentially growing KHT fibrosarcoma cells and EMT-6
murine sarcoma cells were used in the present experiments.
The cells were maintained in vitro in alpha-minimum essential
medium (ax-MEM) supplemented with 10% fetal bovine
serum (FBS) and 0.1 mg ml - kanamycin. The cells were
re-established from frozen stock at 3 month intervals and
were tested routinely for mycoplasma.
Animals
Inbred female C3H/HeJ and Balb/c mice were purchased
from Jackson Laboratories (Bar Harbor, ME, USA) and
were 8-12 weeks old when used in experiments.
Reagents
Nigericin, DIDS and EIPA were purchased from Sigma (St
Louis, MO, USA). Nigericin was dissolved in 10% ethanol
solution for assays in vitro and in 70% ethanol solution for
osmotic pump infusion. DIDS and EIPA were dissolved in
10% dimethyl sulphoxide (DMSO) for in vitro survival assays
and DIDS was dissolved in 70% DMSO for pump infusion.
2',7'-Bis-(2-Carboxyethyl)-5-(and 6)-carboxyfluorescein acet-
oxymethyl ester (BCECF-AM) was purchased from Mole-
cular Probes (Eugene, OR, USA).
In vitro survival assays
In most experiments, cell survival was assessed after varying
duration of exposure to drugs at pHe 6.8 and 7.2. Medium
(a-MEM + 10% FBS) was buffered to pH. 6.8 or 7.2 by
adding MES (25 mM) and MOPS (25 mM) respectively, and
was exposed to humidified 95% air/5% carbon dioxide. The
PHe of the medium was checked after 18 h preincubation, re-
adjusted by adding hydrochloric acid or sodium hydroxide
and sterilised by passing through a 0.22 pm filter. Exponen-
tially growing tumour cells were detached from their flasks
using 0.025% trypsin and 0.01% EDTA, and 2 x 105 cells
were seeded into four 250 mm dishes in each group. After 3 h
incubation to allow attachment of cells, various drugs were
added; control cultures were treated with diluents. The pH of
the medium was checked periodically. After varying periods
of exposure to drugs, cells in one dish from each group were
trypsinised, resuspended and counted. Serial dilutions of cells
were then plated in triplicate in ax-MEM +10% FBS. After
8-9 days, colonies were stained with methylene blue and
counted. The surviving fraction (SF) was calculated
according to:
cell number in suspension treated
cell number in suspension control
plating efficacy treated
plating efficacy control
Here the control conditions refer to untreated cells at
PHe 7.2. To evaluate the influence of small differences in
pH, on cell survival, some experiments were also performed
at pH, 6.7 and 6.9.
Measurement of the activity of Na+/H+ and Na+-dependent
HCO3-/CL- exchangers
Intracellular pH (pHi) was measured as described previously
(Boyer and Tannock, 1992). Briefly, cells grown as a
monolayer on glass coverslips were loaded with BCECF-
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AM. The coverslip was then placed into a cuvette using a
specially designed holder aligned at an angle of 30° to the
excitation beam. Fluorescence was determined using an
Aminco Bowman Series 2 luminescence spectrometer (SLM
Instrument, NY, USA) with excitation and emission
wavelengths set to 495 nm and 525 nm respectively. To
determine the activities of the Na+/H+ antiport and the Na+-
dependent HCO3-/Cl- exchanger, cells were first acidified to
pHi approximately 6.5 or 6.8 by placing cells in NMG
containing ammonium chloride for 30 min followed by
replacement with NMG. The activity of the Na+/H+
antiport in the presence or absence of EIPA was quantified
by adding sodium chloride to the cuvette. Activity of the
Na+-dependent HCO3-/Cl- exchanger in the presence or
absence of DIDS was quantified by adding sodium
bicarbonate to the cuvette in the presence of EIPA. H+
efflux via each exchanger was calculated as described
previously (Boyer and Tannock, 1992).
Long-term exposure to drugs in vivo
KHT or EMT-6 tumours were generated by intramuscular
injection of 1 x 106 cells into the left hind leg of syngeneic
C3H/HeJ or Balb/c mice respectively. Growth of tumour was
monitored by passing the tumour-bearing leg through a strip
of lucite with graded size holes, and tumour weight was
estimated from the diameter of the tumour-bearing leg using
a previously defined calibration curve. Mice were used in
experiments when their tumours had grown to about 0.5 g in
weight, which took approximately 7 days.
Alzet micro osmoticpumps (model 1003D, Alza, CA, USA),
with a capacity of 100 pl and which pumped the fluid at a
steady rate of 1 pl h-'for 72 h, were implanted into mice. The
pumps were loaded with various concentrations of nigericin
with or without hydralazine. In some experiments, DIDS and/
or EIPA were placed in a separate pump since nigeri-
cin+hydralazine and DIDS formed an insoluble precipitate if
combined together at high concentration. The pumps contain-
ing nigericin were transplanted into the abdominal cavity of
tumour-bearing mice and those containing DIDS were
implanted into the subcutaneous region of the dorsum of the
mice. Tumour size and body weight were measured daily.
Four days after implantation of the pump(s), i.e. 24 h after
termination of the period of continuous infusion of drugs,
each tumour was excised, weighed, and minced with scissors
in phosphate-buffered saline (PBS). A single-cell suspension
was obtained by enzymatic digestion with trypsin (Difco) and
DNAase I (Sigma) and dye-excluding cells were counted with
a haemocytometer. The suspensions were diluted and plated
in triplicate in a-MEM + 10% FBS (Hasuda et al., 1994).
After 8-10 days, cells were fixed and stained with methylene
blue and colonies were counted. Surviving fraction per
tumour was calculated according to:
SF/tumour = (cells/gram treated ) x tumour weight treated
cells/gram control ) x tumour weight control
x plating efficacy treated
plating efficacy control
Measurement of tissue pHe
Mice bearing the KHT or EMT-6 tumours were anaesthe-
tised with sodium pentobarbital given i.p. at a dose of
50 mg kg-'. The pHe was measured using a miniature glass
electrode in a 21 gauge needle (model MI-408B, Microelec-
trodes) against a silver-silver chloride reference electrode
(model MI-402, Microelectrodes) using a pH-meter (model
pH103, Corning). The reference electrode was inserted
subcutaneously on the back and the pH electrode was
inserted in the tumour or muscle after incising the overlying
skin. Measurements of pHe were made at 50 to 75 gm
increments along a single track at a depth of 3-5 mm intoChronic inhibiton of pH regulation
M Yamagata and IF Tannock
the tumour. A minimum of three pHe measurements per
tumour were recorded (Newell et al., 1993). The effect of
continuous infusion of hydralazine on tumour pHe was
evaluated in comparison with bolus injection. The dose of
hydralazine by bolus peritoneal injection was 10 mg kg-'.
For continuous infusion, the concentration of hydralazine in




Table I shows rates of H+ efflux in KHT and EMT-6 cells.
When the cells were acidified to pHi 6.5, the rate of H+ efflux
via the Na+/H+ exchanger was higher than that via the Na+-
dependent HCO3-/Cl- exchanger in both cell lines. As
expected (Boyer and Tannock, 1992), the activity of both
exchangers tended to be lower in the cell lines at pHi 6.8 than
at pHi 6.5, but the Na+-dependent HCO3-/Cl- exchanger
was then quantitatively more important.
In vitro studies
During 72 h exposure, the pH, ofmedium was relatively stable
with maximum changes of<0.1 pH units from baseline at
pH, 7.2 and pH, 6.8. Figure la shows cell growth during long-
term exposure to nigericin (0.033 gM) with or without EIPA
(0.5 gM), these doses are about one-tenth of the minimum
doses that are cytotoxic following short-term (i.e. up to 6 h)
exposure at pH, 6.5. Minimal suppression of cell growth was
observed with drug treatment at pH, 7.2. Control cells at
PHe 6.8 grew slowly, and there was loss of cells exposed to
nigericin +EIPA at pH. 6.8. Surviving fractions under these
conditions are shown in Figure lb. Exposure of controls for
48-72 h to pH, 6.8 led to a surviving fraction of0.03-0.10 in
multiple experiments. Nigericin (0.033 gM) caused time-
dependent cell killing of KHT tumour cells at pHe 6.8 with a
survival fraction of0.0017 at 72 h as compared with untreated
cells at pHe 7.2 (surviving fraction approximately 0.06 as
compared with untreated cells at pHe 6.8). Cell killing was
increased minimally in the presence of EIPA.
The dose-dependent effects of EIPA and DIDS combined
with nigericin (0.033 gM) on the survival of KHT cells are
shown in Figure 2: Only minor effects were observed for
EIPA at concentrations up to 5 gM (Figure 2a). A
concentration of 0.4 mM DIDS was highly toxic to cells
when used alone, and 0.1 mM DIDS enhanced cytotoxicity of
nigericin with survival fraction reduced approximately 100-
fold compared with nigericin alone (Figure 2b).
The dose-dependent effects of nigericin on surviving
fraction of KHT and EMT-6 cells following 72 h exposure
at pHe 6.8 or 7.2 are shown in Figure 3a and 3b respectively.
Cell killing by nigericin was enhanced in the presence of
0.05 mM DIDS, and by DIDS + EIPA (5 /uM).
The effects of pHe on survival of KHT and EMT-6 cells
following 72 h exposure to nigericin with or without DIDS
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Figure 1 Growth (a) and survival (b) of KHT cells during 72h
exposure to nigericin 0.033,UM with or without EIPA 0.5 um at
pHe7.2 or 6.8 in vitro. Open symbols are for data at pHe7.2 and
closed symbols are for data at pHe6.8. f1, Control (diluent only);
<O, nigericin alone; 0, nigericin and EIPA. Each point represents
the mean+standard deviation from three experiments.
Table I Rate of H+ efflux (in mm H+ min-') in KHT and EMT-6 cells
pHi after acidification
Activity ofexchangers pHi 6.5 pHi 6.8
KHT
Na+/H + exchanger 7.0+0.2 1.6+0.2
Na+-dependent HCO3-/Cl- exchanger 6.3+0.3 4.1+0.4
Both combined 13.9+0.6 6.9+0.6
EMT-6
Na+/H+ exchanger 5.9+0.2 1.8+0.2
Na+-dependent HCO3-/Cl- exchanger 3.7+0.3 4.0+0.4
Both combined 10.3+0.5 8.0+0.7
Results have been corrected for differences in buffering capacity.
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Figure 2 Effects of varying concentration of EIPA (a) or DIDS
(b) alone or with nigericin (0.033pM) on survival of KHT cells
after 72h exposure in vitro. Open symbols are for data at pHe7.2
and closed symbols are for data at pHe6.8. Ol, Without nigericin;
0, with nigericin. Points represent means+standard deviation
from three or more experiments.
to pHe, with a decrease in survival of 10-fold or greater for a
decrement of 0.1 pH unit. At pHe 6.7, survival of KHT cells
exposed to nigericin +DIDS with or without EIPA was below
the limit of detection.
In vivo experiments
Micro-osmotic pumps were loaded with 0.6, 2.0 or
6.0 mg ml-' nigericin and implanted into mice. The
estimated total release of nigericin over 72 h is about 2.2,
7.2 and 22 mg kg-1 body weight, and all of these doses were
tolerated by mice. No severe early weight loss or late side-
effects up to 2 weeks were observed. The maximum tolerated
dose is close to 22 mg kg-', as when DIDS (10 mg ml-') was
Figure 3 Effect of varying concentration of nigericin on survival
of KHT (a) and EMT-6 (b) cells after 72h exposure with or
without DIDS (50 Mm) or DIDS plus EIPA (5gM). Open symbols
are for data at pHe7.2 and closed symbols are for data at pHe6.8.
Ol, Nicericin alone; O, nigericin with DIDS; 0, nigericin with
DIDS and EIPA. Points represent means+standard deviation
from three experiments.
added to the pumps death of the animals was observed; this
compared with a maximum tolerated dose of 2.5 mg kg-1
nigericin by bolus injection (Hasuda et al., 1994). Neither
weight loss nor abnormal behaviour was observed with
administration up to 2 mg ml-' nigericin and 10 mg ml-'
DIDS from the osmotic pumps.
Our unpublished data on pharmacokinetics of EIPA show
a half-life of about 30 min in plasma of mice with slow
conversion to the less potent amiloride, the concentration of
which is still lower than that of EIPA up to 2 h later.
Although EIPA administered from osmotic pumps containing
a concentration of 3 mg ml-' was not toxic to mice, the
combination of nigericin+DIDS+hydralazine +EIPA
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The growth of KHT tumours during continuous 72 h
exposure to various concentrations of nigericin with or
without DIDS is shown in Figure 5a. Continuous adminis-
tration of nigericin caused significant delay of tumour
growth, which was enhanced in the presence of DIDS. The
mean rate of regrowth was also slower than that of control
tumours after these treatments. Figure 5b shows the surviving
fraction per tumour: nigericin caused dose-dependent killing
of KHT cells in mice when given by 72 h infusion, although
the effect of nigericin at the highest tolerated dose was to
reduce survival only to approximately 10'1. There was slight
enhancement of cell killing in the presence of DIDS. The
relationship between growth delay and surviving fraction is
known to be compex owing to cell killing, environmental
effects on potentially lethal damage, anti-proliferative effects
and the proliferation and removal of damaged cells. The
differences in survival fraction between each treated group
and control shown in Figure 5b are consistent with or greater
than the difference in tumour weight after 72 h treatment,











Measurement of tumour pHe and acidification by hydralazine
Measurements of pHe in KHT tumours are indicated in
Figure 6. Estimates of pHe after administration of
hydralazine were significantly lower than estimates of pHe
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Figure 4 Effect of pH,, on survival of KHT (a) or EMT-6 (b)
cells exposed for 72h to various agents. El, control (diluent only);
O, nigericin (0.033/M); 0, nigericin with DIDS (50 M); A,
nigericin with DIDS and EIPA (5pM). Each point represents
mean+standard deviation from three experiments.
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Figure 5 Growth of KHT tumours in mice during continuous
infusion of agents from osmotic pumps. O, Diluents alone in
pump; O>, 0.6mgml- 1 nigericin; 0, 2.0mgml-1 nigericin; A,
6.0mgml- 1 nigericin. Open and closed symbols represent
nigericin alone and nigericin with 10mgml-l DIDS respec-
tively. Each point represents mean+standard deviation from four
or more tumours. (b) Surviving fraction per KHT tumours after
72h continuous infusion of varying concentration of nigericin
with or without 10mgml- 1 DIDS using osmotic pumps. El,
Nigericin alone; 0, nigericin and DIDS. Each point represents
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pH, after bolus injection was observed only up to 4 h with a
maximal decrease at 2 h after injection, whereas that
obtained by continuous infusion lasted throughout the
period of infusion.
Table II indicates surviving fractions of cells in KHT and
EMT-6 tumours of mice treated with continuous 72 h
infusions of nigericin, hydralazine and DIDS via two
infusion pumps. Mice were able to tolerate this combination
of drugs and there were no animal deaths up to 2 weeks. The
combination of nigericin and hydralazine caused an
approximately 2-fold increase in cell killing as compared
with nigericin alone. If DIDS was given with this
combination of agents, the surviving fraction per tumour
was reduced to about 0.02-0.03.
When EIPA was added to the second osmotic pump
together with DIDS, this led to death of Balb/c mice
implanted with EMT-6 tumours. C3H mice bearing KHT
tumours were able to tolerate this treatment. EIPA caused a
marked augmentation in cell killing by the combination of
nigericin, DIDS and hydralazine with a surviving fraction per
tumour reduced approximately 10-fold compared with the
combination of the drugs without EIPA.
Discussion
The ionophore nigericin, which lowers pHi by allowing
exchange of intracellular K+ for extracellular H+, has been
shown to be cytotoxic to cultured cells at pHe.<6.5 (Rotin et
al., 1987). The average values of pHe in solid tumours,
however, are usually about pHe 6.9, which is only 0.4-
0.5 pH units lower than those in normal tissues (Wike-
Hooley et al., 1984). These values can be lowered slightly by
vasodilator drugs (Newell et al., 1992) or by infusion of
glucose with or without insulin (Hwang et al., 1991; Jahde et
al., 1992). In the present study, pH, 6.8 was selected as
representative of the pHe that might be achieved in tumours,
and long-term exposures of up to 72 h to low concentrations
of nigericin were shown to kill tumour cells at pHe 6.8 in
vitro. This observation indicates the potential for continuous
administration of nigericin to kill cells in solid tumours as
compared with normal tissues based on differences in pHe
(6.8 vs 7.2).
We attempted to enhance the cytotoxicity of nigericin with
DIDS, which is an inhibitor of the Na+-dependent HCO3-/
Cl- exchanger, and with EIPA, which is an inhibitor of the
Na+/H+ exchanger, as both of the exchangers may have
important roles in regulating pHi under acidic conditions
(Cassel et al., 1988; Grinstein et al., 1989). In previous
experiments, short-term exposure to EIPA or DIDS increased
the killing of tumour cells by nigericin (Maidorn et al., 1993;
Luo and Tannock, 1994) when used at pHe 6.5. We measured
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Figure 6 Extracellular pH (pHe) in KHT tumours with or
without treatment with hydralazine by bolus injection (*) or by
continuous infusion (0). E], Control. The dose of hydralazine by
bolus injection was 10mgkg-1. The concentration of hydralazine
in osmotic pumps was 12.5mgml-1, leading to delivery of
approximately 36mgkg- body weight over 72h (i.e. 12.5 gh-1)
Values are mean+s.d. Each point comprised four or more
tumours. Values at 2h after bolus injection, and at 24h and 48h
after start of the infusion, are significantly different from control
(P<0.05, paired t-test).
results, which indicate that the activity of the Na+-dependent
HCO3-/Cl- exchanger is quantitatively more important in
regulating pHi at values of pHe just below the physiological
range (Boyer and Tannock, 1992). Consistent with this
observation, we found that EIPA alone enhanced cell killing
of KHT cells by nigericin only slightly at pH, 6.8, whereas
DIDS caused a greater enhancement of cell killing by
nigericin. However, if EIPA was given in combination with
nigericin and DIDS, there was increased cell killing at
PHe 6.8 in culture, so there may be therapeutic potential
from pharmacological inhibition of both exchangers.
We demonstrated that small differences in pHe between
pH 6.7 and 6.9 greatly affected the degree of killing by
nigericin with or without EIPA or DIDS in vitro. This
exquisite sensitivity to pHe suggests that there is considerable
potential in combining the current approaches with treat-
ments that lower pHe in tumour tissue.
Our in vivo experiments have shown that chronic
administration of nigericin can lead to a decrease in
surviving fraction in both KHT and EMT-6 tumours, and
that this effect is augmented by hydralazine, which inhibits
tumour blood flow and lowers tumour pHi as well as pHe
(Bhujwalla et al., 1990). The increase in cell killing caused by
hydralazine could be due to acidification of tumour or to
Table II Surviving fraction per tumour for KHT and EMT-6 tumours following various treatments
Treatment Tumour weight (g) No. of cells g-1 (x 107) SF/tumour
KHT
Contol 1.17+0.45 1.68+0.52 1.0
Nigericin 2.0 mgml-' 0.75+0.10 1.21+0.37 0.18+0.07
Hydralazine 12.5mgml 1 0.85+0.12 1.23+0.44 0.40+0.08
Nigericin 2.0 mgml + hydralazine 12.5 mgml 0.55+0.18 0.79+0.26 0.10+0.06
Nigericin 2.0 mgml + hydralazine 12.5 mgml - + 0.52+0.06 0.45+0.07 0.03+0.01
DIDS 10 mgml-
Nigericin 2.0 mgml + hydralazine 12.5 mgmlV- + 0.30+0.11 0.05+0.02 0.002+0.001
DIDS 10 mgml-l +EIPA 3 mgml-
EMT-6
Control 1.12+0.06 1.48+0.49 1.0
Nigericin 2.0 mgml-l + hydralazine 12.5 mgml-1 0.95+0.05 0.71 +0.24 0.22+0.08
Nigericin 2.0 mgml 1 + hydralazine 12.5 mgml 1 + 0.57+0.11 0.18+0.11 0.02+0.01
DIDS 10 mgml-l
The drugs were given by 72h infusion from micro-osmotic pumps and the concentration ofeach drug in the pump is indicated.
Values are mean+s.d. Each group comprised four or more tumours from three or more individual experiments.
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trapping of the drugs within the tumour as a result of
decreased blood flow (Parkins et al.. 1994).
We found that DIDS enhanced cell killin2 in Xvitro by
nigericin. although cell survi%val was reduced only to
approximately 0.02 at tolerated doses in EMT-6 tumours in
the presence of hydralazine. The effect of DIDS was greater
than that in the absence of hydralazine. This obsernation is
consistent with results obtained in vitro. which showed that
DIDS enhanced cell killing by nigericin at lower pH.
Although we could apply EIPA only to C3H HeJ mice by
continuous infusion. the greatest cell killing was observed
when both exchangers were inhibited. consistent with results
obtained in culture. This suggests the importance of
inhibition of both the Na- H- antiport and the Na-
dependent HCO - Cl- exchanger in maximising this
approach to tumour therapy.
There is evidence that the acute administration of agents
that acidify cells may enhance the effects of hyperthermia
against experimental tumours (Miyakoshi et al.. 1986:
Ruifrok et al.. 1987: Kim et al.. 1991: Song et al.. 1993).
Our current results using chronic administration of such
agents might hav-e relev,ance to studies of hyperthermia.
although repeated or prolonged heat treatments within 72 h
w-ould only be useful if thermotolerance were inhibited.
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